Causes of Chronic Kidney Disease and Their Associations with Cardiovascular Risk and Disease in a Sub-Saharan Low-Income Population

References

• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272. doi:10.1016/S0140-6736(13)60687-X
   PubMed Web of Science ®Google Scholar
• Kassebaum NJ, Arora M, Barber RM, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1603–1658. doi:10.1016/S0140-6736(16)31460-X
   PubMed Web of Science ®Google Scholar
• Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis. BMC Nephrol. 2018;19(1):125. doi:10.1186/s12882-018-0930-5
   PubMed Web of Science ®Google Scholar
• Dessein PH, Hsu HC, Tsang L, et al. Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis. PLoS One. 2015;10(3):e0121693. doi:10.1371/journal.pone.0121693
   PubMed Web of Science ®Google Scholar
• Kaze AD, Schutte AE, Erqou S, Kengne AP, Echouffo-Tcheugui JB. Prevalence of hypertension in older people in Africa: a systematic review and meta-analysis. J Hypertens. 2017;35(7):1345–1352. doi:10.1097/HJH.0000000000001345
   PubMed Web of Science ®Google Scholar
• Werfalli M, Engel ME, Musekiwa A, Kengne AP, Levitt NS. The prevalence of type 2 diabetes among older people in Africa: a systematic review. Lancet Diabetes Endocrinol. 2016;4(1):72–84. doi:10.1016/S2213-8587(15)00363-0
   PubMed Web of Science ®Google Scholar
• Øvrehus MA, Oldereid TS, Dadfar A, et al. Clinical phenotypes and long-term prognosis in white patients with biopsy-verified hypertensive nephrosclerosis. Kidney Int Rep. 2020;5(3):339–347. doi:10.1016/j.ekir.2019.12.010
   PubMed Web of Science ®Google Scholar
• Correa-Rotter R, Méndez Durán A, Vallejos A, et al. Unmet Needs of CKD in Latin America: a review from expert virtual working group. Kidney Int Rep. 2023;8(5):954–967. doi:10.1016/j.ekir.2023.02.1082
   PubMed Web of Science ®Google Scholar
• Liyanage T, Toyama T, Hockham C, et al. Prevalence of chronic kidney disease in Asia: a systematic review and analysis. BMJ Glob Health. 2022;7(1):e007525. doi:10.1136/bmjgh-2021-007525
   PubMed Web of Science ®Google Scholar
• Spence JD, Rayner BL. Hypertension in blacks: individualized therapy based on renin/aldosterone phenotyping. Hypertension. 2018;72(2):263–269. doi:10.1161/HYPERTENSIONAHA.118.11064
   PubMed Web of Science ®Google Scholar
• Ugwu CLJ, Ncayiyana JR. Spatial disparities of HIV prevalence in South Africa. Do sociodemographic, behavioral, and biological factors explain this spatial variability? Front Public Health. 2022;10. doi:10.3389/fpubh.2022.994277
   Web of Science ®Google Scholar
• Naicker S, Rahmania S, Kopp JB. HIV and chronic kidney disease. Clin Nephrol. 2015;83(Suppl 1):S32–S38. doi:10.5414/CNP83S032
   PubMed Web of Science ®Google Scholar
• Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157–1172. doi:10.1161/CIRCULATIONAHA.120.050686
   PubMed Web of Science ®Google Scholar
• Feinstein MJ. HIV, subclinical cardiovascular disease, and clinical progression: insights from immunologic heterogeneity. JAMA. 2022;328(10):931–932. doi:10.1001/jama.2022.15226
   PubMed Web of Science ®Google Scholar
• Ameer OZ. Hypertension in chronic kidney disease: what lies behind the scene. Front Pharmacol. 2022;13. doi:10.3389/fphar.2022.949260
   PubMedGoogle Scholar
• Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circu Res. 2023;132(8):1050–1063. doi:10.1161/CIRCRESAHA.122.321762
   PubMed Web of Science ®Google Scholar
• Magriço R, Bigotte Vieira M, Viegas Dias C, Leitão L, Neves JS. BP reduction, kidney function decline, and cardiovascular events in patients without CKD. Clin J Am Soc Nephrol. 2018;13(1):73–80. doi:10.2215/CJN.05510517
   PubMed Web of Science ®Google Scholar
• Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82(4):388–400. doi:10.1038/ki.2012.131
   PubMed Web of Science ®Google Scholar
• Maeda T, Yokota S, Nishi T, et al. Association between pulse pressure and progression of chronic kidney disease. Sci Rep. 2021;11(1):23275. doi:10.1038/s41598-021-02809-8
   PubMed Web of Science ®Google Scholar
• Raina R, Polaconda S, Nair N, et al. Association of pulse pressure, pulse pressure index, and ambulatory arterial stiffness index with kidney function in a cross‐sectional pediatric chronic kidney disease cohort from the CKiD study. J Clin Hypertens. 2020;22(6):1059–1069. doi:10.1111/jch.13905
   Web of Science ®Google Scholar
• Safar ME, Asmar R, Benetos A, et al. Interaction Between Hypertension and Arterial Stiffness. Hypertension. 2018;72(4):796–805. doi:10.1161/HYPERTENSIONAHA.118.11212
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Rong J, Larson MG, et al. Longitudinal hemodynamic correlates of and sex differences in the evolution of blood pressure across the adult lifespan: the Framingham heart study. J Am Heart Assoc. 2023;12(12):e027329. doi:10.1161/JAHA.122.027329
   PubMed Web of Science ®Google Scholar
• Mitchell GF, Lacourcière Y, Ouellet JP, et al. Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108(13):1592–1598. doi:10.1161/01.CIR.0000093435.04334.1F
   PubMed Web of Science ®Google Scholar
• Hsu HC, Norton GR, Robinson C, Woodiwiss AJ, Dessein PH. Potential determinants of the E/e’ ratio in non-dialysis compared with dialysis patients. Nephrology. 2021;26(12):988–998. doi:10.1111/nep.13948
   PubMed Web of Science ®Google Scholar
• Pickup L, Radhakrishnan A, Townend JN, Ferro CJ. Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk factor? Curr Opin Nephrol Hypertens. 2019;28(6):527–536. doi:10.1097/MNH.0000000000000535
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1–S87. doi:10.1016/j.kint.2020.11.003
   PubMedGoogle Scholar
• Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• Solomon A, Christian BF, Woodiwiss AJ, Norton GR, Dessein PH. Burden of depressive symptoms in South African public healthcare patients with established rheumatoid arthritis: a case-control study. Clin Exp Rheumatol. 2011;29(3):506–512.
   PubMed Web of Science ®Google Scholar
• Klug E. South African Heart Association (S A Heart), Lipid and Atherosclerosis Society of Southern Africa (LASSA). South African dyslipidaemia guideline consensus statement. S Afr Med J. 2012;102(3 Pt 2):178–187. doi:10.7196/samj.5502
   PubMed Web of Science ®Google Scholar
• Hsu HC, Robinson C, Norton GR, Woodiwiss AJ, Dessein PH. The optimal haemoglobin target in dialysis patients may be determined by its contrasting effects on arterial stiffness and pressure pulsatility. Int J Nephrol Renovasc Dis. 2020;13:385–395. doi:10.2147/IJNRD.S285168
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Cox RH. Pressure dependence of the mechanical properties of arteries in vivo. Am J Physiol. 1975;229(5):1371–1375. doi:10.1152/ajplegacy.1975.229.5.1371
   PubMedGoogle Scholar
• Avolio A. Arterial Stiffness. Pulse. 2013;1(1):14–28. doi:10.1159/000348620
   PubMedGoogle Scholar
• DeMers D, Wachs D. Physiology, mean arterial pressure. In: StatPearls. StatPearls Publishing; 2023. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538226/. Accessed January 7, 2024.
   Google Scholar
• Mitchell GF. Arterial stiffness and hypertension: chicken or egg? Hypertension. 2014;64(2):210–214. doi:10.1161/HYPERTENSIONAHA.114.03449
   PubMed Web of Science ®Google Scholar
• Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998;97(14):1411–1420. doi:10.1161/01.cir.97.14.1411
   PubMed Web of Science ®Google Scholar
• Abraham HMA, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015;38(1):33–54. doi:10.1007/s40264-014-0239-7
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature. J Cell & Mol Med. 2010. doi:10.1111/j.1582-4934.2010.01056.x
   PubMed Web of Science ®Google Scholar
• Rapoport RM, Soleimani M. Mechanism of thiazide diuretic arterial pressure reduction: the search continues. Front Pharmacol. 2019;10:815. doi:10.3389/fphar.2019.00815
   PubMed Web of Science ®Google Scholar
• Adam CA, Anghel R, Marcu DTM, Mitu O, Roca M, Mitu F. Impact of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging—What Do We Know So Far? (A Narrative Review). Life. 2022;12(6):803. doi:10.3390/life12060803
   PubMedGoogle Scholar
• Naseri MW, Esmat HA, Bahee MD. Prevalence of hypertension in Type-2 diabetes mellitus. Ann Med Surg. 2022;78:103758. doi:10.1016/j.amsu.2022.103758
   PubMed Web of Science ®Google Scholar
• Naha S, Gardner MJ, Khangura D, Kurukulasuriya LR, Sowers JR. Hypertension in Diabetes. In: Feingold KR, Anawalt B, Blackman MR, et al. editors. Endotext. MDText.com, Inc.; 2000. Available from: http://www.ncbi.nlm.nih.gov/books/NBK279027/. Accessed January 7, 2024.
   Google Scholar
• Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37(4):1053–1059. doi:10.1161/01.hyp.37.4.1053
   PubMed Web of Science ®Google Scholar
• Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi:10.1038/s41581-019-0244-2
   PubMed Web of Science ®Google Scholar
• SPRINT Research Group. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021;384(20):1921–1930. doi:10.1056/NEJMoa1901281
   PubMed Web of Science ®Google Scholar
• Georgianos PI, Agarwal R. Resistant hypertension in Chronic Kidney Disease (CKD): prevalence, treatment particularities, and research Agenda. Curr Hypertens Rep. 2020;22(10):84. doi:10.1007/s11906-020-01081-x
   PubMed Web of Science ®Google Scholar
• Yuan J, Zou XR, Han SP, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 2017;18(1):23. doi:10.1186/s12882-017-0441-9
   PubMed Web of Science ®Google Scholar
• Fabian J, Gondwe M, Mayindi N, et al. Chronic kidney disease (CKD) and associated risk in rural South Africa: a population-based cohort study. Wellcome Open Res. 2022;7:236. doi:10.12688/wellcomeopenres.18016.2
   PubMedGoogle Scholar
• Poggio ED, McClelland RL, Blank KN, et al. Systematic review and meta-analysis of native kidney biopsy complications. Clin J Am Soc Nephrol. 2020;15(11):1595–1602. doi:10.2215/CJN.04710420
   PubMed Web of Science ®Google Scholar